Intrahepatic and perihilar cholangiocarcinoma, in particular, grew faster in young patients than in older patients. The report affirms research from other Western countries suggesting such a trend.
If you or a loved one has gallbladder or bile duct cancer, you may be interested in learning more about treatments for it. For a long time, the standard treatment options for this cancer type were ...
A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB). This is an ASCO Meeting ...
The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology show that chemotherapy combining three different types ...
Biliary tract infection (BTI) is a disease with high morbidity and mortality, often associated with structural abnormalities such as common bile duct stones and malignant tumors. Although Pseudomonas ...
Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...
A biliary stent is a small tube that a doctor inserts into the liver to allow bile to drain typically and relieve symptoms of a blocked bile duct. A blocked bile duct may occur with liver cancer and ...
On March 14, 2026, Shanghai East International Medical Center (SEIMC) achieved a major milestone in global minimally invasive biliary treatment by successfully completing its first overseas clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results